Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Jahns, BG; Stein, W; Hilfiker-Kleiner, D; Pieske, B; Emons, G.
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
Am J Obstet Gynecol. 2008; 199(4):e5-e6
Doi: 10.1016/j.ajog.2008.06.051
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Pieske Burkert Mathias
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Bromocriptine - pharmacology Bromocriptine - therapeutic use
- Cardiomyopathies - drug therapy Cardiomyopathies - metabolism
- Cathepsin D - metabolism
- Female -
- HELLP Syndrome -
- Heart Failure - drug therapy Heart Failure - metabolism
- Hormone Antagonists - pharmacology Hormone Antagonists - therapeutic use
- Humans -
- Myocardium - metabolism
- Pregnancy -
- Pregnancy Complications, Cardiovascular - drug therapy Pregnancy Complications, Cardiovascular - metabolism
- Prolactin - antagonists and inhibitors
- Find related publications in this database (Keywords)
- bromocriptine
- cathepsin D
- peripartum cardiomyopathy
- prolactin